137 related articles for article (PubMed ID: 16505197)
1. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload.
Zile MR; Baicu CF; Stroud RE; Van Laer AO; Jones JA; Patel R; Mukherjee R; Spinale FG
Circ Heart Fail; 2014 Mar; 7(2):340-50. PubMed ID: 24395927
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.
Shinde AV; Su Y; Palanski BA; Fujikura K; Garcia MJ; Frangogiannis NG
J Mol Cell Cardiol; 2018 Apr; 117():36-48. PubMed ID: 29481819
[TBL] [Abstract][Full Text] [Related]
4. Variable phenotype in murine transverse aortic constriction.
Mohammed SF; Storlie JR; Oehler EA; Bowen LA; Korinek J; Lam CS; Simari RD; Burnett JC; Redfield MM
Cardiovasc Pathol; 2012; 21(3):188-98. PubMed ID: 21764606
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload.
Frolova EG; Sopko N; Blech L; Popovic ZB; Li J; Vasanji A; Drumm C; Krukovets I; Jain MK; Penn MS; Plow EF; Stenina OI
FASEB J; 2012 Jun; 26(6):2363-73. PubMed ID: 22362893
[TBL] [Abstract][Full Text] [Related]
6. MAP Kinase Phosphatase-5 Deficiency Protects Against Pressure Overload-Induced Cardiac Fibrosis.
Zhong C; Min K; Zhao Z; Zhang C; Gao E; Huang Y; Zhang X; Baldini M; Roy R; Yang X; Koch WJ; Bennett AM; Yu J
Front Immunol; 2021; 12():790511. PubMed ID: 34992607
[TBL] [Abstract][Full Text] [Related]
7. Role of macrophages in regression of myocardial fibrosis following alleviation of left ventricular pressure overload.
Neff LS; Biggs RM; Zhang Y; Van Laer AO; Baicu CF; Subramanian S; Berto S; DeLeon-Pennell K; Zile MR; Bradshaw AD
Am J Physiol Heart Circ Physiol; 2024 May; 326(5):H1204-H1218. PubMed ID: 38363214
[TBL] [Abstract][Full Text] [Related]
8. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.
Ducharme A; Frantz S; Aikawa M; Rabkin E; Lindsey M; Rohde LE; Schoen FJ; Kelly RA; Werb Z; Libby P; Lee RT
J Clin Invest; 2000 Jul; 106(1):55-62. PubMed ID: 10880048
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of aldose reductase exacerbates early pressure overload-induced cardiac dysfunction and autophagy in mice.
Baba SP; Zhang D; Singh M; Dassanayaka S; Xie Z; Jagatheesan G; Zhao J; Schmidtke VK; Brittian KR; Merchant ML; Conklin DJ; Jones SP; Bhatnagar A
J Mol Cell Cardiol; 2018 May; 118():183-192. PubMed ID: 29627295
[TBL] [Abstract][Full Text] [Related]
10. Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodeling.
Hutchinson KR; Saripalli C; Chung CS; Granzier H
J Mol Cell Cardiol; 2015 Feb; 79():104-14. PubMed ID: 25450617
[TBL] [Abstract][Full Text] [Related]
11. The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling.
Andenæs K; Lunde IG; Mohammadzadeh N; Dahl CP; Aronsen JM; Strand ME; Palmero S; Sjaastad I; Christensen G; Engebretsen KVT; Tønnessen T
PLoS One; 2018; 13(7):e0201422. PubMed ID: 30052659
[TBL] [Abstract][Full Text] [Related]
12. UCP1-dependent brown adipose activation accelerates cardiac metabolic remodeling and reduces initial hypertrophic and fibrotic responses to pathological stress.
Challa AA; Vidal P; Maurya SK; Maurya CK; Baer LA; Wang Y; James NM; Pardeshi PJ; Fasano M; Carley AN; Stanford KI; Lewandowski ED
FASEB J; 2024 Jun; 38(11):e23709. PubMed ID: 38809700
[TBL] [Abstract][Full Text] [Related]
13. Regional variations in ex-vivo diffusion tensor anisotropy are associated with cardiomyocyte remodeling in rats after left ventricular pressure overload.
Carruth ED; Teh I; Schneider JE; McCulloch AD; Omens JH; Frank LR
J Cardiovasc Magn Reson; 2020 Apr; 22(1):21. PubMed ID: 32241289
[TBL] [Abstract][Full Text] [Related]
14. Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling.
Coelho-Filho OR; Shah RV; Mitchell R; Neilan TG; Moreno H; Simonson B; Kwong R; Rosenzweig A; Das S; Jerosch-Herold M
Circulation; 2013 Sep; 128(11):1225-33. PubMed ID: 23912910
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF).
Cho S; Dadson K; Sung HK; Ayansola O; Mirzaesmaeili A; Noskovicova N; Zhao Y; Cheung K; Radisic M; Hinz B; Sater AAA; Hsu HH; Lopaschuk GD; Sweeney G
Biomed Pharmacother; 2024 Feb; 171():116119. PubMed ID: 38181714
[TBL] [Abstract][Full Text] [Related]
16. Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes.
Lukowski R; Rybalkin SD; Loga F; Leiss V; Beavo JA; Hofmann F
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5646-51. PubMed ID: 20212138
[TBL] [Abstract][Full Text] [Related]
17. Proline metabolic reprogramming modulates cardiac remodeling induced by pressure overload in the heart.
Lv Q; Li D; Zhao L; Yu P; Tao Y; Zhu Q; Wang Y; Wang M; Fu G; Shang M; Zhang W
Sci Adv; 2024 May; 10(19):eadl3549. PubMed ID: 38718121
[TBL] [Abstract][Full Text] [Related]
18. Age- and sex-dependent differences in extracellular matrix metabolism associate with cardiac functional and structural changes.
Grilo GA; Shaver PR; Stoffel HJ; Morrow CA; Johnson OT; Iyer RP; de Castro Brás LE
J Mol Cell Cardiol; 2020 Feb; 139():62-74. PubMed ID: 31978395
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin 5 levels are limiting in preserving cardiac function and suppressing fibrosis in response to pressure overload.
Guo AH; Baliira R; Skinner ME; Kumar S; Andren A; Zhang L; Goldsmith RS; Michan S; Davis NJ; Maccani MW; Day SM; Sinclair DA; Brody MJ; Lyssiotis CA; Stein AB; Lombard DB
Sci Rep; 2022 Jul; 12(1):12258. PubMed ID: 35851833
[TBL] [Abstract][Full Text] [Related]
20. ATF6 protects against protein misfolding during cardiac hypertrophy.
Hofmann C; Aghajani M; Alcock CD; Blackwood EA; Sandmann C; Herzog N; Groß J; Plate L; Wiseman RL; Kaufman RJ; Katus HA; Jakobi T; Völkers M; Glembotski CC; Doroudgar S
J Mol Cell Cardiol; 2024 Apr; 189():12-24. PubMed ID: 38401179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
